Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Stichting Hemato-Oncologie voor Volwassenen Nederland
University Hospital, Lille
University of Turin, Italy
National Institutes of Health Clinical Center (CC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Fondazione EMN Italy Onlus
Fondazione EMN Italy Onlus
Janssen Research & Development, LLC
University of Leeds
Duke University
Oncotherapeutics
Oncotherapeutics
Oncotherapeutics
Canadian Cancer Trials Group
Fondazione EMN Italy Onlus
H. Lee Moffitt Cancer Center and Research Institute
University Hospital Heidelberg
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Basque Health Service
Celgene
Mayo Clinic
Amgen
National Institutes of Health Clinical Center (CC)
Takeda
Amgen
SWOG Cancer Research Network
PETHEMA Foundation
University of Turin, Italy
Fondazione EMN Italy Onlus
Nantes University Hospital
UMC Utrecht
SWOG Cancer Research Network
Janssen Research & Development, LLC
Millennium Pharmaceuticals, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
National Cancer Institute (NCI)
SWOG Cancer Research Network
Northwestern University
National Institutes of Health Clinical Center (CC)
Grupo de Estudos Multicentricos em Onco-Hematologia
University of Leipzig